Scientists have discovered a new method for brain cancer patients to determine which patients might benefit from immunotherapy drugs. This discovery will revolutionize the treatment of brain cancer.
Some glioblastoma tumors respond well to immunotherapy, but there is currently no way to perform a non-incisional biopsy. Incisional biopsies carry risks of infection and bleeding.
Therefore, a biopsy is rarely performed before surgery to remove the tumor, which means patients are not getting the best treatment.
Now researchers have developed a new imaging technique that could help pinpoint which patients would benefit from immunotherapy drugs without a risky biopsy.
Experts are hopeful that new imaging techniques will soon be able to offer specific treatments for glioblastoma patients.
